Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | GLA | P06280 | 1/20 | 0.55 |
| ▸ | CA3 | P07451 | 1/20 | 0.55 |
| ▸ | CA4 | P22748 | 1/20 | 0.55 |
| ▸ | CA9 | Q16790 | 1/20 | 0.55 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.55 |
| ▸ | ESR1 | P03372 | 5/20 | 0.43 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | MMP3 | P08254 | 1/20 | 0.40 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.40 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.39 |
| ▸ | ABAT | P80404 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenol SCHEMBL28211059 | 1.00 | TDP1 (0.55) | TDP1CA12CA1CA2GLA | |
| Phenol SCHEMBL11329973 | 0.98 | TDP1 (0.52) | TDP1CA12CA1CA2GLA | |
| Phenol SCHEMBL27614600 | 0.81 | TDP1 (0.65) | TDP1CA12CA1CA2GLA | |
| Phenol SCHEMBL28182274 | 0.81 | TDP1 (0.65) | TDP1CA12CA1CA2GLA | |
| Phenol SCHEMBL9509973 | 0.81 | CA12 (0.73) | TDP1CA12CA1CA2GLA | |
| Phenol SCHEMBL662758 | 0.78 | TDP1 (0.69) | TDP1CA12CA1CA2GLA | |
| Phenol SCHEMBL30534252 | 0.78 | TDP1 (0.69) | TDP1CA12CA1CA2GLA | |
| Phenol SCHEMBL16735107 | 0.78 | TDP1 (0.69) | TDP1CA12CA1CA2GLA | |
| Phenol SCHEMBL5799389 | 0.78 | TDP1 (0.69) | TDP1CA12CA1CA2GLA | |
| Phenol SCHEMBL29391610 | 0.78 | TDP1 (0.69) | TDP1CA12CA1CA2GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170233357-A1 | PHENOLIC EPOXY COMPOUNDS | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2017-08-17 | — | — | US | claimed |
| US-20170233522-A1 | PHENOLIC EPOXY COMPOUNDS | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2017-08-17 | — | — | US | claimed |
| US-20160009672-A1 | PHENOLIC EPOXY COMPOUNDS | CRESTLINE DIRECT FINANCE, L.P. | 2016-01-14 | — | — | US | claimed |
| WO-2014126625-A1 | MULTI-FUNCTIONAL ACRYLATES | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2014-08-21 | — | — | WO | claimed |
| WO-2014126626-A1 | PHENOLIC EPOXY COMPOUNDS | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2014-08-21 | — | — | WO | claimed |
| US-10106494-B2 | Gemini surfactant and their use | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2018-10-23 | — | — | US | disclosed |
| US-9890130-B2 | Phenolic epoxy compounds | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2018-02-13 | — | — | US | disclosed |
| US-9834522-B2 | Multi-functional acrylates | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2017-12-05 | — | — | US | disclosed |
| US-20170233522-A1 | PHENOLIC EPOXY COMPOUNDS | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2017-08-17 | — | — | US | disclosed |
| US-20170233357-A1 | PHENOLIC EPOXY COMPOUNDS | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2017-08-17 | — | — | US | disclosed |
| US-20160368863-A1 | NOVEL GEMINI SURFACTANT AND THEIR USE | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2016-12-22 | — | — | US | disclosed |
| EP-3077364-A1 | NOVEL GEMINI SURFACTANTS AND THEIR USE | Empire Technology Development LLC (US) | 2016-10-12 | — | — | EP | disclosed |
| US-20160009672-A1 | PHENOLIC EPOXY COMPOUNDS | CRESTLINE DIRECT FINANCE, L.P. | 2016-01-14 | — | — | US | disclosed |
| US-20150376149-A1 | MULTI-FUNCTIONAL ACRYLATES | CRESTLINE DIRECT FINANCE, L.P. | 2015-12-31 | — | — | US | disclosed |
| WO-2015084304-A1 | NOVEL GEMINI SURFACTANTS AND THEIR USE | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2015-06-11 | — | — | WO | disclosed |
| WO-2014126626-A1 | PHENOLIC EPOXY COMPOUNDS | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2014-08-21 | — | — | WO | disclosed |
| WO-2014126625-A1 | MULTI-FUNCTIONAL ACRYLATES | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2014-08-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10106494-B2 | Gemini surfactant and their use | GEMIN4, GMNN, GEMIN5 | TDP1 2566/4885CA12 3385/4885CA1 3323/4885 |
| US-20170233522-A1 | PHENOLIC EPOXY COMPOUNDS | ESR1, PTGES, COMT | TDP1 3394/4885CA12 3759/4885CA1 4199/4885 |
| US-20160009672-A1 | PHENOLIC EPOXY COMPOUNDS | COMT, ESR1, EED | TDP1 3085/4885CA12 4071/4885CA1 4391/4885 |
| US-20170233357-A1 | PHENOLIC EPOXY COMPOUNDS | COMT, ESR1, EED | TDP1 3085/4885CA12 4071/4885CA1 4391/4885 |
| US-20150376149-A1 | MULTI-FUNCTIONAL ACRYLATES | AAAS, PNMT, PFAS | TDP1 594/4885CA12 4036/4885CA1 4232/4885 |
| US-20160368863-A1 | NOVEL GEMINI SURFACTANT AND THEIR USE | GEMIN4, GEMIN5, GMNN | TDP1 2473/4885CA12 3650/4885CA1 3546/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.